Mevinolin enhances osteogenic genes (ALP, type I collagen and osteocalcin), CD44, CD47 and CD51 expression during osteogenic differentiation

In this study, we evaluated the effect of mevinolin on the expressions of osteogenic genes and surface molecules expression during osteogenesis. D1 cells were cultured in osteogenic differentiation medium (ODM) for 6 days, treated with mevinolin for 2 days, and then subjected to alizarin red S stain...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Life sciences (1973) 2009-02, Vol.84 (9), p.290-295
Hauptverfasser: Kim, Hyung Keun, Cho, Sang Gwon, Kim, Ji Hyun, Doan, Thi Kim Phuong, Hu, Qin Sheng, Ulhaq, Rehan, Song, Eun Kyoo, Yoon, Taek Rim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 295
container_issue 9
container_start_page 290
container_title Life sciences (1973)
container_volume 84
creator Kim, Hyung Keun
Cho, Sang Gwon
Kim, Ji Hyun
Doan, Thi Kim Phuong
Hu, Qin Sheng
Ulhaq, Rehan
Song, Eun Kyoo
Yoon, Taek Rim
description In this study, we evaluated the effect of mevinolin on the expressions of osteogenic genes and surface molecules expression during osteogenesis. D1 cells were cultured in osteogenic differentiation medium (ODM) for 6 days, treated with mevinolin for 2 days, and then subjected to alizarin red S staining, MTT assays, alkaline phosphatase (ALP) activity determinations, energy dispersive X-ray spectrophotometry (EDX), real-time PCR, Western blot, fluorescence microscopy and FACS analysis. Mevinolin is commonly prescribed and widely used to lower cholesterol levels, and offers an important, effective approach to the treatment of hypercholesterolemia and arteriosclerosis. However, the direct effect of mevinolin on osteogenesis in vitro has not been clarified. ODM has been previously shown to increase the osteoblast differentiation of D1 cells. In the present study, we investigated the expressions of osteogenic genes and surface molecules during osteoblast differentiation induced by mevinolin. We found that the induction of ALP, type I collagen, osteocalcin, CD44, CD47 and CD51 by mevinolin is responsible for the osteoblastic differentiation of D1 cells. Our data show that mevinolin enhances the expressions of proteins and surface molecules related to osteogenesis.
doi_str_mv 10.1016/j.lfs.2008.12.017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66931367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320508005134</els_id><sourcerecordid>20533889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-76e63f4662128719666d95c022854daa0812efbd926ad51cb87736693beadb503</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EokvhAbggnxBITfDYiZ2IU7UFWmkRHOBsOfakeJW1Fztb0XfgofF2V6Kn9jKWxt_80sxHyGtgNTCQH9b1NOaaM9bVwGsG6glZQKf6ikkBT8mCMd5UgrP2hLzIec0Ya1slnpMT6EFy1ogF-fsVb3yIkw8Uwy8TLGYa84zxGoO3tNTSeHe--n5G59st0itq4zSZ0qcmuANqzWR9eH9GlxdNc1fV3efyogWKf7YJc_YxULdLPlzfj3d-HDFhmL2ZC_GSPBvNlPHV8T0lPz9_-rG8rFbfvlwtz1eVFR2fKyVRirGRkgPvFPRSSte3lnHetY0zhnXAcRxcz6VxLdihU0pI2YsBjRtaJk7J20PuNsXfO8yz3vhssewVMO6y3rMgpHoULKcVouv6AsIBtCnmnHDU2-Q3Jt1qYHrvSq91caX3rjRwXVyVmTfH8N2wQfd_4iinAB8PAJZb3HhMOluPRZHzCe2sXfQPxP8DKCqjTg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20533889</pqid></control><display><type>article</type><title>Mevinolin enhances osteogenic genes (ALP, type I collagen and osteocalcin), CD44, CD47 and CD51 expression during osteogenic differentiation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kim, Hyung Keun ; Cho, Sang Gwon ; Kim, Ji Hyun ; Doan, Thi Kim Phuong ; Hu, Qin Sheng ; Ulhaq, Rehan ; Song, Eun Kyoo ; Yoon, Taek Rim</creator><creatorcontrib>Kim, Hyung Keun ; Cho, Sang Gwon ; Kim, Ji Hyun ; Doan, Thi Kim Phuong ; Hu, Qin Sheng ; Ulhaq, Rehan ; Song, Eun Kyoo ; Yoon, Taek Rim</creatorcontrib><description>In this study, we evaluated the effect of mevinolin on the expressions of osteogenic genes and surface molecules expression during osteogenesis. D1 cells were cultured in osteogenic differentiation medium (ODM) for 6 days, treated with mevinolin for 2 days, and then subjected to alizarin red S staining, MTT assays, alkaline phosphatase (ALP) activity determinations, energy dispersive X-ray spectrophotometry (EDX), real-time PCR, Western blot, fluorescence microscopy and FACS analysis. Mevinolin is commonly prescribed and widely used to lower cholesterol levels, and offers an important, effective approach to the treatment of hypercholesterolemia and arteriosclerosis. However, the direct effect of mevinolin on osteogenesis in vitro has not been clarified. ODM has been previously shown to increase the osteoblast differentiation of D1 cells. In the present study, we investigated the expressions of osteogenic genes and surface molecules during osteoblast differentiation induced by mevinolin. We found that the induction of ALP, type I collagen, osteocalcin, CD44, CD47 and CD51 by mevinolin is responsible for the osteoblastic differentiation of D1 cells. Our data show that mevinolin enhances the expressions of proteins and surface molecules related to osteogenesis.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2008.12.017</identifier><identifier>PMID: 19162043</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Alkaline Phosphatase - genetics ; Alkaline Phosphatase - metabolism ; ALP ; Animals ; Bone Marrow Cells - cytology ; CD44 ; CD47 ; CD47 Antigen - genetics ; CD47 Antigen - metabolism ; CD51 ; Cell Differentiation - drug effects ; Cell Differentiation - physiology ; Cell Line ; Collagen Type I - genetics ; Collagen Type I - metabolism ; Gene Expression Regulation - drug effects ; Humans ; Hyaluronan Receptors - genetics ; Hyaluronan Receptors - metabolism ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology ; Integrin alphaV - genetics ; Integrin alphaV - metabolism ; Lovastatin - pharmacology ; Mice ; Multipotent Stem Cells - cytology ; Multipotent Stem Cells - physiology ; Osteocalcin ; Osteocalcin - genetics ; Osteocalcin - metabolism ; Osteogenesis - drug effects ; Osteogenesis - genetics ; Statin ; Stromal Cells - cytology ; Type I collagen, Mevinolin</subject><ispartof>Life sciences (1973), 2009-02, Vol.84 (9), p.290-295</ispartof><rights>2008 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-76e63f4662128719666d95c022854daa0812efbd926ad51cb87736693beadb503</citedby><cites>FETCH-LOGICAL-c382t-76e63f4662128719666d95c022854daa0812efbd926ad51cb87736693beadb503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0024320508005134$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19162043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Hyung Keun</creatorcontrib><creatorcontrib>Cho, Sang Gwon</creatorcontrib><creatorcontrib>Kim, Ji Hyun</creatorcontrib><creatorcontrib>Doan, Thi Kim Phuong</creatorcontrib><creatorcontrib>Hu, Qin Sheng</creatorcontrib><creatorcontrib>Ulhaq, Rehan</creatorcontrib><creatorcontrib>Song, Eun Kyoo</creatorcontrib><creatorcontrib>Yoon, Taek Rim</creatorcontrib><title>Mevinolin enhances osteogenic genes (ALP, type I collagen and osteocalcin), CD44, CD47 and CD51 expression during osteogenic differentiation</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>In this study, we evaluated the effect of mevinolin on the expressions of osteogenic genes and surface molecules expression during osteogenesis. D1 cells were cultured in osteogenic differentiation medium (ODM) for 6 days, treated with mevinolin for 2 days, and then subjected to alizarin red S staining, MTT assays, alkaline phosphatase (ALP) activity determinations, energy dispersive X-ray spectrophotometry (EDX), real-time PCR, Western blot, fluorescence microscopy and FACS analysis. Mevinolin is commonly prescribed and widely used to lower cholesterol levels, and offers an important, effective approach to the treatment of hypercholesterolemia and arteriosclerosis. However, the direct effect of mevinolin on osteogenesis in vitro has not been clarified. ODM has been previously shown to increase the osteoblast differentiation of D1 cells. In the present study, we investigated the expressions of osteogenic genes and surface molecules during osteoblast differentiation induced by mevinolin. We found that the induction of ALP, type I collagen, osteocalcin, CD44, CD47 and CD51 by mevinolin is responsible for the osteoblastic differentiation of D1 cells. Our data show that mevinolin enhances the expressions of proteins and surface molecules related to osteogenesis.</description><subject>Alkaline Phosphatase - genetics</subject><subject>Alkaline Phosphatase - metabolism</subject><subject>ALP</subject><subject>Animals</subject><subject>Bone Marrow Cells - cytology</subject><subject>CD44</subject><subject>CD47</subject><subject>CD47 Antigen - genetics</subject><subject>CD47 Antigen - metabolism</subject><subject>CD51</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Differentiation - physiology</subject><subject>Cell Line</subject><subject>Collagen Type I - genetics</subject><subject>Collagen Type I - metabolism</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Humans</subject><subject>Hyaluronan Receptors - genetics</subject><subject>Hyaluronan Receptors - metabolism</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology</subject><subject>Integrin alphaV - genetics</subject><subject>Integrin alphaV - metabolism</subject><subject>Lovastatin - pharmacology</subject><subject>Mice</subject><subject>Multipotent Stem Cells - cytology</subject><subject>Multipotent Stem Cells - physiology</subject><subject>Osteocalcin</subject><subject>Osteocalcin - genetics</subject><subject>Osteocalcin - metabolism</subject><subject>Osteogenesis - drug effects</subject><subject>Osteogenesis - genetics</subject><subject>Statin</subject><subject>Stromal Cells - cytology</subject><subject>Type I collagen, Mevinolin</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi0EokvhAbggnxBITfDYiZ2IU7UFWmkRHOBsOfakeJW1Fztb0XfgofF2V6Kn9jKWxt_80sxHyGtgNTCQH9b1NOaaM9bVwGsG6glZQKf6ikkBT8mCMd5UgrP2hLzIec0Ya1slnpMT6EFy1ogF-fsVb3yIkw8Uwy8TLGYa84zxGoO3tNTSeHe--n5G59st0itq4zSZ0qcmuANqzWR9eH9GlxdNc1fV3efyogWKf7YJc_YxULdLPlzfj3d-HDFhmL2ZC_GSPBvNlPHV8T0lPz9_-rG8rFbfvlwtz1eVFR2fKyVRirGRkgPvFPRSSte3lnHetY0zhnXAcRxcz6VxLdihU0pI2YsBjRtaJk7J20PuNsXfO8yz3vhssewVMO6y3rMgpHoULKcVouv6AsIBtCnmnHDU2-Q3Jt1qYHrvSq91caX3rjRwXVyVmTfH8N2wQfd_4iinAB8PAJZb3HhMOluPRZHzCe2sXfQPxP8DKCqjTg</recordid><startdate>20090227</startdate><enddate>20090227</enddate><creator>Kim, Hyung Keun</creator><creator>Cho, Sang Gwon</creator><creator>Kim, Ji Hyun</creator><creator>Doan, Thi Kim Phuong</creator><creator>Hu, Qin Sheng</creator><creator>Ulhaq, Rehan</creator><creator>Song, Eun Kyoo</creator><creator>Yoon, Taek Rim</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20090227</creationdate><title>Mevinolin enhances osteogenic genes (ALP, type I collagen and osteocalcin), CD44, CD47 and CD51 expression during osteogenic differentiation</title><author>Kim, Hyung Keun ; Cho, Sang Gwon ; Kim, Ji Hyun ; Doan, Thi Kim Phuong ; Hu, Qin Sheng ; Ulhaq, Rehan ; Song, Eun Kyoo ; Yoon, Taek Rim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-76e63f4662128719666d95c022854daa0812efbd926ad51cb87736693beadb503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Alkaline Phosphatase - genetics</topic><topic>Alkaline Phosphatase - metabolism</topic><topic>ALP</topic><topic>Animals</topic><topic>Bone Marrow Cells - cytology</topic><topic>CD44</topic><topic>CD47</topic><topic>CD47 Antigen - genetics</topic><topic>CD47 Antigen - metabolism</topic><topic>CD51</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Differentiation - physiology</topic><topic>Cell Line</topic><topic>Collagen Type I - genetics</topic><topic>Collagen Type I - metabolism</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Humans</topic><topic>Hyaluronan Receptors - genetics</topic><topic>Hyaluronan Receptors - metabolism</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology</topic><topic>Integrin alphaV - genetics</topic><topic>Integrin alphaV - metabolism</topic><topic>Lovastatin - pharmacology</topic><topic>Mice</topic><topic>Multipotent Stem Cells - cytology</topic><topic>Multipotent Stem Cells - physiology</topic><topic>Osteocalcin</topic><topic>Osteocalcin - genetics</topic><topic>Osteocalcin - metabolism</topic><topic>Osteogenesis - drug effects</topic><topic>Osteogenesis - genetics</topic><topic>Statin</topic><topic>Stromal Cells - cytology</topic><topic>Type I collagen, Mevinolin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Hyung Keun</creatorcontrib><creatorcontrib>Cho, Sang Gwon</creatorcontrib><creatorcontrib>Kim, Ji Hyun</creatorcontrib><creatorcontrib>Doan, Thi Kim Phuong</creatorcontrib><creatorcontrib>Hu, Qin Sheng</creatorcontrib><creatorcontrib>Ulhaq, Rehan</creatorcontrib><creatorcontrib>Song, Eun Kyoo</creatorcontrib><creatorcontrib>Yoon, Taek Rim</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Hyung Keun</au><au>Cho, Sang Gwon</au><au>Kim, Ji Hyun</au><au>Doan, Thi Kim Phuong</au><au>Hu, Qin Sheng</au><au>Ulhaq, Rehan</au><au>Song, Eun Kyoo</au><au>Yoon, Taek Rim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mevinolin enhances osteogenic genes (ALP, type I collagen and osteocalcin), CD44, CD47 and CD51 expression during osteogenic differentiation</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2009-02-27</date><risdate>2009</risdate><volume>84</volume><issue>9</issue><spage>290</spage><epage>295</epage><pages>290-295</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>In this study, we evaluated the effect of mevinolin on the expressions of osteogenic genes and surface molecules expression during osteogenesis. D1 cells were cultured in osteogenic differentiation medium (ODM) for 6 days, treated with mevinolin for 2 days, and then subjected to alizarin red S staining, MTT assays, alkaline phosphatase (ALP) activity determinations, energy dispersive X-ray spectrophotometry (EDX), real-time PCR, Western blot, fluorescence microscopy and FACS analysis. Mevinolin is commonly prescribed and widely used to lower cholesterol levels, and offers an important, effective approach to the treatment of hypercholesterolemia and arteriosclerosis. However, the direct effect of mevinolin on osteogenesis in vitro has not been clarified. ODM has been previously shown to increase the osteoblast differentiation of D1 cells. In the present study, we investigated the expressions of osteogenic genes and surface molecules during osteoblast differentiation induced by mevinolin. We found that the induction of ALP, type I collagen, osteocalcin, CD44, CD47 and CD51 by mevinolin is responsible for the osteoblastic differentiation of D1 cells. Our data show that mevinolin enhances the expressions of proteins and surface molecules related to osteogenesis.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>19162043</pmid><doi>10.1016/j.lfs.2008.12.017</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 2009-02, Vol.84 (9), p.290-295
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_66931367
source MEDLINE; Elsevier ScienceDirect Journals
subjects Alkaline Phosphatase - genetics
Alkaline Phosphatase - metabolism
ALP
Animals
Bone Marrow Cells - cytology
CD44
CD47
CD47 Antigen - genetics
CD47 Antigen - metabolism
CD51
Cell Differentiation - drug effects
Cell Differentiation - physiology
Cell Line
Collagen Type I - genetics
Collagen Type I - metabolism
Gene Expression Regulation - drug effects
Humans
Hyaluronan Receptors - genetics
Hyaluronan Receptors - metabolism
Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology
Integrin alphaV - genetics
Integrin alphaV - metabolism
Lovastatin - pharmacology
Mice
Multipotent Stem Cells - cytology
Multipotent Stem Cells - physiology
Osteocalcin
Osteocalcin - genetics
Osteocalcin - metabolism
Osteogenesis - drug effects
Osteogenesis - genetics
Statin
Stromal Cells - cytology
Type I collagen, Mevinolin
title Mevinolin enhances osteogenic genes (ALP, type I collagen and osteocalcin), CD44, CD47 and CD51 expression during osteogenic differentiation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T15%3A38%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mevinolin%20enhances%20osteogenic%20genes%20(ALP,%20type%20I%20collagen%20and%20osteocalcin),%20CD44,%20CD47%20and%20CD51%20expression%20during%20osteogenic%20differentiation&rft.jtitle=Life%20sciences%20(1973)&rft.au=Kim,%20Hyung%20Keun&rft.date=2009-02-27&rft.volume=84&rft.issue=9&rft.spage=290&rft.epage=295&rft.pages=290-295&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2008.12.017&rft_dat=%3Cproquest_cross%3E20533889%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20533889&rft_id=info:pmid/19162043&rft_els_id=S0024320508005134&rfr_iscdi=true